Back to top

Analyst Blog

World's largest dialysis company Fresenius Medical Care (FMS - Snapshot Report) revealed an agreement with Heritage California ACO (“HCACO”), an Accountable Care Organization affiliated to Heritage Provider Network, to provide composite health management for HCACO enrollees suffering from End Stage Renal Disease. The understanding is along the lines of a population health program under which Fresenius Medical Care will strive to enhance outcomes and curtail cost of care.

Dialysis sustains life by removing surplus fluids and cleansing waste material from the blood stream when a patient’s kidneys stop functioning.

The population health initiative is tailored after the 5-year model project conducted by Fresenius Health Partners (subsidiary of Fresenius Medical Care) on Medicare enrollees supported by dialysis. The project, completed in December 2010, was conducted with Centers for Medicare & Medicaid Services (“CMS”). Benefits from the project include lower health care costs, reduced mortality and a fall in hospitalizations.

Heritage California ACO has an affiliation with the Heritage Provider Network group of entities.  Heritage Provider Network provides health care to more than 700,000 persons. It operates in eight counties of California, New York and Arizona. 

Fresenius is the largest provider of products and services for patients undergoing dialysis treatment. The company’s principal competitor in the U.S. is DaVita Inc. (DVA - Analyst Report), which provides dialysis services for patients suffering from chronic kidney failure or end stage renal disease. Fresenius also competes with Baxter International (BAX - Analyst Report) in certain niches such as peritoneal dialysis products.

The company continues to register strong operating results in the North American as well as overseas markets. The integration of acquisitions is also expected to be accretive to Fresenius’ earnings in the near term. However, the contagion of lingering economic problems in Europe remains a matter of concern.

The stock carries a Zacks Rank #3 (Hold). Cyberonics Inc. (CYBX - Analyst Report) carries a Zacks Rank #1 (Strong Buy) and is expected to do well.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
STRATTEC SE… STRT 80.24 +3.00%
PATTERSON-U… PTEN 34.54 +2.98%